Epitel, Inc. closed a $26 million Series B round to expand commercial access to its wireless EEG monitoring system, the Salt Lake City digital health company announced. Same investors, bigger bet
This is the second time Catalyst Health Ventures and Genoa Ventures have co-led a round for Epitel.